Sanuwave Health Return on Tangible Equity 2010-2025 | SNWV
Current and historical return on tangible equity values for Sanuwave Health (SNWV) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Sanuwave Health Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $-0.03B | $-0.03B | 75.86% |
| 2024-12-31 | $-0.03B | $-0.02B | 62.44% |
| 2024-09-30 | $0.00B | $-0.07B | 1.69% |
| 2024-06-30 | $0.00B | $-0.05B | 6.58% |
| 2024-03-31 | $-0.02B | $-0.06B | 27.17% |
| 2023-12-31 | $-0.03B | $-0.06B | 38.24% |
| 2023-09-30 | $-0.05B | $-0.08B | 74.07% |
| 2023-06-30 | $-0.03B | $-0.07B | 45.57% |
| 2023-03-31 | $-0.02B | $-0.07B | 34.12% |
| 2022-12-31 | $-0.01B | $-0.05B | 20.51% |
| 2022-09-30 | $-0.01B | $-0.05B | 26.80% |
| 2022-06-30 | $-0.02B | $-0.05B | 33.33% |
| 2022-03-31 | $-0.03B | $-0.05B | 58.70% |
| 2021-12-31 | $-0.03B | $-0.05B | 65.85% |
| 2021-09-30 | $-0.03B | $-0.04B | 85.71% |
| 2021-06-30 | $-0.04B | $-0.04B | 121.88% |
| 2021-03-31 | $-0.03B | $-0.03B | 130.77% |
| 2020-12-31 | $-0.03B | $-0.03B | 147.13% |
| 2020-09-30 | $-0.02B | $-0.03B | 133.33% |
| 2020-06-30 | $-0.01B | $-0.02B | 101.96% |
| 2020-03-31 | $-0.01B | $-0.01B | 92.31% |
| 2019-12-31 | $-0.01B | $-0.01B | 80.00% |
| 2019-09-30 | $-0.01B | $-0.01B | 66.67% |
| 2019-06-30 | $-0.01B | $-0.02B | 53.33% |
| 2019-03-31 | $-0.01B | $-0.02B | 54.24% |
| 2018-12-31 | $-0.01B | $-0.02B | 84.21% |
| 2018-09-30 | $-0.01B | $-0.01B | 100.00% |
| 2018-06-30 | $-0.01B | $-0.02B | 108.33% |
| 2018-03-31 | $-0.01B | $-0.01B | 107.32% |
| 2017-12-31 | $-0.01B | $-0.01B | 58.82% |
| 2017-09-30 | $0.00B | $-0.01B | 51.61% |
| 2017-06-30 | $0.00B | $-0.01B | 57.14% |
| 2017-03-31 | $0.00B | $-0.01B | 61.54% |
| 2016-12-31 | $-0.01B | $-0.01B | 96.00% |
| 2016-09-30 | $-0.01B | $-0.01B | 83.33% |
| 2016-06-30 | $-0.01B | $-0.01B | 83.33% |
| 2016-03-31 | $-0.01B | $-0.01B | 104.35% |
| 2015-12-31 | $-0.01B | $-0.01B | 100.00% |
| 2015-09-30 | $0.00B | $-0.01B | 100.00% |
| 2015-06-30 | $0.00B | $-0.01B | 145.45% |
| 2015-03-31 | $0.00B | $0.00B | 266.67% |
| 2014-12-31 | $-0.01B | $0.00B | 1200.00% |
| 2014-09-30 | $-0.01B | $0.00B | 400.00% |
| 2014-06-30 | $-0.01B | $0.00B | 307.69% |
| 2014-03-31 | $-0.01B | $0.00B | 138.46% |
| 2013-12-31 | $-0.01B | $-0.01B | 112.82% |
| 2013-09-30 | $-0.01B | $-0.01B | 120.00% |
| 2013-06-30 | $-0.01B | $-0.01B | 90.00% |
| 2013-03-31 | $-0.01B | $-0.01B | 109.09% |
| 2012-12-31 | $-0.01B | $-0.01B | 92.31% |
| 2012-09-30 | $-0.01B | $-0.01B | 114.29% |
| 2012-06-30 | $-0.01B | $-0.01B | 186.67% |
| 2012-03-31 | $-0.01B | $-0.01B | 444.44% |
| 2011-12-31 | $-0.01B | $0.00B | 285.71% |
| 2011-09-30 | $-0.02B | $0.00B | 260.87% |
| 2011-06-30 | $-0.02B | $0.00B | 172.97% |
| 2011-03-31 | $-0.02B | $-0.01B | 120.00% |
| 2010-12-31 | $-0.02B | $-0.01B | 128.00% |
| 2010-09-30 | $-0.01B | $-0.02B | 104.35% |
| 2010-06-30 | $-0.01B | $-0.01B | 129.73% |
| 2010-03-31 | $-0.01B | $-0.01B | 133.33% |
| 2009-12-31 | $-0.01B | $-0.01B | 200.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.256B | $0.033B |
| SANUWAVE Health, Inc. is engaged in the development and commercialization of non-invasive, biological response-activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's product candidates include its proprietary PACE technology applicable in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions; and dermaPACE for treatment of the skin and subcutaneous soft tissue. The Company's products help in activating biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. SANUWAVE Health, Inc. is based in Alpharetta, USA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.146B | 27.67 |
| Boston Scientific (BSX) | United States | $150.504B | 37.68 |
| Stryker (SYK) | United States | $142.511B | 29.80 |
| EssilorLuxottica (ESLOY) | France | $130.598B | 0.00 |
| Medtronic (MDT) | Ireland | $110.517B | 15.67 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.287B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.240B | 26.92 |
| ResMed (RMD) | United States | $36.670B | 27.54 |
| Agilent Technologies (A) | United States | $32.977B | 21.50 |
| GE HealthCare Technologies (GEHC) | United States | $32.574B | 15.47 |
| Terumo (TRUMY) | Japan | $26.206B | 34.04 |
| Insulet (PODD) | United States | $21.421B | 84.09 |
| Koninklijke Philips (PHG) | Netherlands | $20.782B | 14.94 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.848B | 11.46 |
| Baxter (BAX) | United States | $15.354B | 11.46 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.539B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.087B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.271B | 21.82 |
| Lantheus Holdings (LNTH) | United States | $5.391B | 13.60 |
| Prestige Consumer Healthcare (PBH) | United States | $4.135B | 18.47 |
| Perrigo (PRGO) | Ireland | $3.612B | 9.15 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.315B | 15.10 |
| ICU Medical (ICUI) | United States | $3.199B | 23.59 |
| Envista Holdings (NVST) | United States | $3.124B | 25.96 |
| GN Store Nord (GNNDY) | Denmark | $2.272B | 18.82 |
| QuidelOrtho (QDEL) | United States | $1.896B | 13.04 |
| LeMaitre Vascular (LMAT) | United States | $1.830B | 40.91 |
| AtriCure (ATRC) | United States | $1.614B | 0.00 |
| Acuren (TIC) | United States | $1.361B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.148B | 11.66 |
| Neogen (NEOG) | United States | $1.146B | 14.67 |
| Green Thumb Industries (GTBIF) | United States | $1.048B | 23.57 |
| BioLife Solutions (BLFS) | United States | $1.033B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.991B | 12.67 |
| InMode (INMD) | Israel | $0.845B | 8.52 |
| Kestra Medical Technologies (KMTS) | United States | $0.774B | 0.00 |
| CeriBell (CBLL) | United States | $0.641B | 0.00 |
| Evolus (EOLS) | United States | $0.596B | 0.00 |
| Owens & Minor (OMI) | United States | $0.583B | 4.83 |
| Capricor Therapeutics (CAPR) | United States | $0.557B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.549B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.532B | 0.00 |
| Valneva SE (VALN) | France | $0.500B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.387B | 0.00 |
| SNDL (SNDL) | Canada | $0.336B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.331B | 58.80 |
| VAREX IMAGING (VREX) | United States | $0.320B | 11.77 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.307B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.261B | 22.00 |
| Cerus (CERS) | United States | $0.250B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.247B | 0.00 |
| ZimVie (ZIMV) | United States | $0.244B | 11.08 |
| Canopy Growth (CGC) | Canada | $0.243B | 0.00 |
| Quanterix (QTRX) | United States | $0.238B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.233B | 0.00 |
| Biote (BTMD) | United States | $0.215B | 6.05 |
| OraSure Technologies (OSUR) | United States | $0.210B | 0.00 |
| Brainsway (BWAY) | Israel | $0.208B | 54.95 |
| TriSalus Life Sciences (TLSI) | United States | $0.196B | 0.00 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| Organigram Global (OGI) | Canada | $0.184B | 0.00 |
| High Tide (HITI) | Canada | $0.182B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.181B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.175B | 14.28 |
| Exagen (XGN) | United States | $0.165B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.136B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.128B | 15.72 |
| Jin Medical (ZJYL) | China | $0.108B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Fonar (FONR) | United States | $0.087B | 11.26 |
| MacroGenics (MGNX) | United States | $0.086B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.082B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.080B | 0.00 |
| Agape ATP (ATPC) | $0.076B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.075B | 0.00 |
| Zynex (ZYXI) | United States | $0.071B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Apyx Medical (APYX) | United States | $0.067B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.058B | 0.00 |
| ImmuCell (ICCC) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.043B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 54.00 |
| United-Guardian (UG) | United States | $0.038B | 12.97 |
| Rockwell Medical (RMTI) | United States | $0.031B | 0.00 |
| Safety Shot (SHOT) | United States | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| INLIF (INLF) | $0.013B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |